Beyond comparison? Questioning the approval process for cardiac devices
This feature requires the newest version of Flash. You can download it here.

February 25, 2013
Recorded: November 6, 2012

"Comparative effectiveness" has become a buzzword in medical research as well as healthcare policy, yet a recent review of cardiovascular device approvals in the US suggests only a minority are ever tested against standard treatment before they are approved for the US market.

Dr Rita Redberg sits down with heartwire's Shelley Wood to talk about what's missing from the approval process and what risks this poses for patients, especially those with implanted devices.

Chair

Shelley Wood
Managing Editor, theheart.org

Ms Wood has disclosed no relevant financial relationships.

Panelists

Rita Redberg MD
Professor of Medicine
Director, Women's Cardiovascular Services
Division of Cardiology
University of California San Francisco Medical Center
San Francisco, CA

Dr Redberg has disclosed no relevant financial relationships.

Related Links: